Philip Scuderi

2.5k total citations
69 papers, 2.1k citations indexed

About

Philip Scuderi is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Philip Scuderi has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 16 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Philip Scuderi's work include Immune Response and Inflammation (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Philip Scuderi is often cited by papers focused on Immune Response and Inflammation (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Philip Scuderi collaborates with scholars based in United States, Canada and Japan. Philip Scuderi's co-authors include Ronald R. Watson, Bernhard Watzl, Eskild Petersen, C. George Ray, Richard Reed, Arshag D. Mooradian, Anita S. Chong, Arthur Raitano, Dan Osterweil and Murray Korc and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Philip Scuderi

68 papers receiving 2.0k citations

Peers

Countries citing papers authored by Philip Scuderi

Since Specialization

Citations

This map shows the geographic impact of Philip Scuderi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Scuderi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Scuderi more than expected).

Fields of papers citing papers by Philip Scuderi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Scuderi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Scuderi. The network helps show where Philip Scuderi may publish in the future.

Co-authorship network of co-authors of Philip Scuderi

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Scuderi. A scholar is included among the top collaborators of Philip Scuderi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Scuderi. Philip Scuderi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells 2012 ·Journal of Biotechnology ·(unknown), (unknown), (unknown), (unknown), Jennifer B. Nixon, (unknown), (unknown), (unknown), Hongbo Xie, (unknown), Hongbin Li, Philip Scuderi, (unknown), Jennifer A. Hunt, Thomas Barnett	20
2	Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model 2011 ·PubMed ·R. Christian Crumrine, Victor J. Marder, Guillaume Taylor, Joseph C. LaManna, (unknown), Philip Scuderi, Stephen R. Petteway, Vikram Arora	17
3	Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2–5 2010 ·Thrombosis and Haemostasis ·(unknown), (unknown), Abha Goyal, Guillermo Moreno, Jennifer A. Hunt, (unknown), Philip Scuderi, Stephen R. Petteway, Valery Novokhatny, Victor J. Marder	5
4	Remifentanil Compared with Alfentanil for Ambulatory Surgery Using Total Intravenous Anesthesia 1997 ·Survey of Anesthesiology ·Beverly K. Philip, Philip Scuderi, Frances Chung, Thomas J. Conahan, W Mäurer, John J. Angel, Surinder K. Kallar, Elizabeth Skinner, Brenda D. Jamerson, Kathryn E. McGoldrick	9
5	Prevention of Rhinovirus Infection in Chimpanzees by Soluble Intercellular Adhesion Molecule-1 1997 ·American Journal of Respiratory and Critical Care Medicine ·E D Huguenel, David E. Cohn, (unknown), J M Greve, Michael A. Fournel, (unknown), Regina Irwin, (unknown), Alan McClelland, Elizabeth Muchmore, A Ohlin, Philip Scuderi	53
6	Remifentanil Compared with Alfentanil for Ambulatory Surgery Using Total Intravenous Anesthesia 1997 ·Anesthesia & Analgesia ·Beverly K. Philip, Philip Scuderi, Frances Chung, Thomas J. Conahan, W Mäurer, John J. Angel, Surinder K. Kallar, Elizabeth Skinner, Brenda D. Jamerson	109
7	The Risk of Peripheral Vein Phlebitis Associated With Chlorhexidine-Coated Catheters A Randomized, Double-Blind Trial 1997 ·Infection Control and Hospital Epidemiology ·Robert J. Sherertz, Jeffrey L. Stephens, (unknown), William Carruth, (unknown), Kenneth D. Hampton, (unknown), (unknown), Philip Scuderi, (unknown), (unknown), Donald D. Solomon	19
8	ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon γ production in interleukin-2-activated T cells 1994 ·Cancer Immunology Immunotherapy ·Anita S. Chong, (unknown), Philip Scuderi, (unknown), Lloyd H. Graf	11
9	Monoclonal antibodies anti-CD3, anti-TCRαβ and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon γ 1992 ·Cancer Immunology Immunotherapy ·Anita S. Chong, Edgar D. Staren, Philip Scuderi	6
10	Upregulation of Interferon-γ Binding by Tumor Necrosis Factor and Lymphotoxin: Disparate Potencies of the Cytokines and Modulation of Their Effects by Phorbol Ester 1991 ·Journal of Interferon Research ·Arthur Raitano, Philip Scuderi, Murray Korc	17
11	Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin 1991 ·Cellular Immunology ·Philip Scuderi, (unknown), (unknown), (unknown), (unknown)	77
12	Phenotypic analyses of lymphokine-activated killer cells that release interferon γ and tumor necrosis factor α 1990 ·Cancer Immunology Immunotherapy ·Anita S. Chong, (unknown), William J. Grimes, Evan M. Hersh, Philip Scuderi	7
13	Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma Cells 1990 ·Pancreas ·Arthur Raitano, Philip Scuderi, Murray Korc	40
14	Decreased Serum Triiodothyronine Is Associated with Increased Concentrations of Tumor Necrosis Factor 1990 ·The Journal of Clinical Endocrinology & Metabolism ·Arshag D. Mooradian, Richard Reed, Dan Osterweil, (unknown), Philip Scuderi	45
15	A phase I trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy 1989 ·Biotherapy ·(unknown), Philip Scuderi, (unknown), Alfred R. Rudolph, Evan M. Hersh	16
16	Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones 1989 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Philip Scuderi, (unknown), (unknown)	20
17	Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor 1989 ·Journal of Clinical Immunology ·(unknown), (unknown), Sydney E. Salmon, Evan M. Hersh, Philip Scuderi	6
18	Characteristics of tumor necrosis factor production in rheumatoid arthritis 1989 ·Cellular Immunology ·David E. Yocum, (unknown), (unknown), James B. Benjamin, ROBERT G. VOLZ, Philip Scuderi	99
19	Recombinant Interferon-γ Stimulates the Production of Human Tumor Necrosis Factor In Vitro 1987 ·Journal of Interferon Research ·Philip Scuderi, (unknown), Arthur Raitano, Thomas M. Grogan, Richard A. Rippe	29
20	Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay. 1987 ·Journal of Clinical Oncology ·S. E. Salmon, Lai-Sang Young, Philip Scuderi, Brendan Clark	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact